TW438587B
(en)
*
|
1995-06-20 |
2001-06-07 |
Takeda Chemical Industries Ltd |
A pharmaceutical composition for prophylaxis and treatment of diabetes
|
NZ286920A
(en)
*
|
1995-07-03 |
1997-06-24 |
Sankyo Co |
Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma
|
EA199800177A1
(ru)
|
1995-08-10 |
1998-10-29 |
Варнер-Ламберт Компани |
Способ снижения количества экзогенного инсулина, вводимого пациенту с инсулиннезависимым сахарным диабетом
|
DK0914158T4
(da)
*
|
1996-04-05 |
2006-03-06 |
Takeda Pharmaceutical |
Farmaceutisk kombination indeholdende en forbindelse med angiotensin II antagonistisk aktivitet og en forbindelse, der öger insulin-sensitiviteten
|
NZ333723A
(en)
|
1996-07-15 |
2000-09-29 |
Sankyo Co |
A synergistic combination of an insulin resistance improving agent and an angiotensin II receptor antagonist or an angiotensin converting enzyme inhibitor
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
US6011049A
(en)
*
|
1997-02-19 |
2000-01-04 |
Warner-Lambert Company |
Combinations for diabetes
|
US5859037A
(en)
*
|
1997-02-19 |
1999-01-12 |
Warner-Lambert Company |
Sulfonylurea-glitazone combinations for diabetes
|
US6291495B1
(en)
|
1997-02-24 |
2001-09-18 |
Robert B. Rieveley |
Method and composition for the treatment of diabetes
|
BR9810172A
(pt)
*
|
1997-06-18 |
2000-08-08 |
Smithkline Beecham Plc |
Tratamento de diabete com tiazolidinadiona e metformina
|
AU778947B2
(en)
*
|
1997-06-18 |
2004-12-23 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and metformin
|
US20010049380A1
(en)
*
|
1997-06-18 |
2001-12-06 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
US20020004515A1
(en)
*
|
1997-06-18 |
2002-01-10 |
Smith Stephen Alistair |
Treatment of diabetes with thiazolidinedione and metformin
|
AU783539B2
(en)
*
|
1997-06-18 |
2005-11-10 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
CA2294385C
(en)
*
|
1997-06-18 |
2007-06-05 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione and sulphonylurea
|
US20020028768A1
(en)
*
|
1997-06-18 |
2002-03-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with rosiglitazone and insulin
|
CA2294134A1
(en)
*
|
1997-06-18 |
1998-12-23 |
Stephen Alistair Smith |
Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
|
GB9715306D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
US20020016287A1
(en)
*
|
1997-07-18 |
2002-02-07 |
Smithkline Beecham P.L.C. |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
AU782419B2
(en)
*
|
1997-07-18 |
2005-07-28 |
Smithkline Beecham Plc |
Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
|
GB9715295D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
GB9715298D0
(en)
*
|
1997-07-18 |
1997-09-24 |
Smithkline Beecham Plc |
Novel method of treatment
|
US7141249B2
(en)
*
|
1997-10-20 |
2006-11-28 |
Dainippon Sumitomo Pharma Co., Ltd. |
Rapidly soluble drug composition
|
US6583157B2
(en)
|
1998-01-29 |
2003-06-24 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
US6200995B1
(en)
|
1998-01-29 |
2001-03-13 |
Tularik Inc. |
PPAR-γ modulators
|
US6099859A
(en)
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US7105552B2
(en)
*
|
1998-05-08 |
2006-09-12 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
US6221897B1
(en)
*
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
ES2255316T3
(es)
*
|
1998-06-30 |
2006-06-16 |
Takeda Pharmaceutical Company Limited |
Composicion farmaceutica para el tratamiento de diabetes.
|
JP2000080047A
(ja)
*
|
1998-06-30 |
2000-03-21 |
Takeda Chem Ind Ltd |
医 薬
|
DE69818444T2
(de)
|
1998-07-15 |
2004-05-06 |
Merck Santé |
Tabletten enthaltend eine Kombination von Glibenclamid und Metformin
|
US6376549B1
(en)
*
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
HUP0104900A3
(en)
*
|
1998-10-29 |
2003-02-28 |
Univ Texas |
Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation
|
AR023700A1
(es)
*
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
EA011633B1
(ru)
*
|
1998-11-12 |
2009-04-28 |
Смитклайн Бичам Плс |
Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов
|
US20040081697A1
(en)
*
|
1998-11-12 |
2004-04-29 |
Smithkline Beecham P.L.C. |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
AP1692A
(en)
*
|
1998-11-12 |
2006-12-12 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
|
US20040102486A1
(en)
*
|
1998-11-12 |
2004-05-27 |
Smithkline Beecham Corporation |
Novel method of treatment
|
US20030153607A1
(en)
*
|
1998-11-12 |
2003-08-14 |
Smithkline Beecham P.L.C. |
Novel composition and use
|
US6958324B2
(en)
*
|
1998-12-02 |
2005-10-25 |
Inotek Pharmaceuticals Corporation |
Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
|
US20080269265A1
(en)
*
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
US6756360B1
(en)
|
1998-12-24 |
2004-06-29 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
|
CN101164618A
(zh)
*
|
1998-12-24 |
2008-04-23 |
症变治疗公司 |
治疗糖尿病的fbp酶抑制剂与胰岛素致敏剂的组合
|
JP4799720B2
(ja)
*
|
1999-01-29 |
2011-10-26 |
武田薬品工業株式会社 |
コーティング処理を施した打錠用杵
|
ATE400426T1
(de)
*
|
1999-01-29 |
2008-07-15 |
Takeda Pharmaceutical |
Verdichtungshammer mit beschichtungsbehandlung
|
GB0001662D0
(en)
*
|
1999-02-06 |
2000-03-15 |
Zeneca Ltd |
Pharmaceutical compositions
|
MXPA01009893A
(es)
*
|
1999-04-01 |
2003-07-28 |
Esperion Therapeutics Inc |
Compuestos con eter, composiciones y usos de estos.
|
US7407978B2
(en)
*
|
1999-04-06 |
2008-08-05 |
Theracos, Inc. |
Heterocyclic analogs of diphenylethylene compounds
|
JP2000355550A
(ja)
*
|
1999-04-14 |
2000-12-26 |
Takeda Chem Ind Ltd |
ケトーシス改善剤
|
TWI249401B
(en)
|
1999-04-14 |
2006-02-21 |
Takeda Chemical Industries Ltd |
Agent for improving ketosis
|
ATE247653T1
(de)
*
|
1999-04-23 |
2003-09-15 |
Smithkline Beecham Plc |
Thiazolidindionderivat und seine verwendung als antidiabetikum
|
GB9910693D0
(en)
*
|
1999-05-07 |
1999-07-07 |
Univ Liverpool |
A compound for use in medicine
|
US6214842B1
(en)
*
|
1999-05-12 |
2001-04-10 |
Michael S. Malamas |
Amino-thiazolidinediones useful in the treatment of insulin resistance and hyperglycemia
|
JP2003502370A
(ja)
*
|
1999-06-18 |
2003-01-21 |
メルク エンド カムパニー インコーポレーテッド |
アリールチアゾリジンジオン誘導体およびアリールオキサゾリジンジオン誘導体
|
PT1133312E
(pt)
|
1999-06-21 |
2007-11-30 |
Lilly Co Eli |
Uso sinergístico de tiazolidinodionas com péptido 1 semelhante ao glucagon e os seus agonistas para tratar diabetes não insulino-dependente
|
JP2003503356A
(ja)
*
|
1999-06-25 |
2003-01-28 |
メドトロニック ミニメド インコーポレイテッド |
多剤糖尿病治療
|
MXPA01013199A
(es)
*
|
1999-06-30 |
2003-08-20 |
Tularik Inc |
Compuestos para la modulacion de la actividad de ppary.
|
AU779730B2
(en)
*
|
1999-06-30 |
2005-02-10 |
Amgen, Inc. |
Compounds for the modulation of PPARgamma activity
|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
AU2005200818B2
(en)
*
|
1999-09-17 |
2008-07-17 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US6878749B2
(en)
*
|
1999-09-17 |
2005-04-12 |
Novartis Ag |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US6559188B1
(en)
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
AR028299A1
(es)
*
|
1999-09-17 |
2003-05-07 |
Novartis Ag |
Una composicion farmaceutica que comprende nateglinida, un proceso para su preparacion y el uso de dicha composicion para la preparacion de un medicamento para el tratamiento de desordenes metabolicos, especialmente diabetes, o de una enfermedad o condicion asociada con diabetes.
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
WO2001024790A1
(fr)
*
|
1999-10-06 |
2001-04-12 |
Kurokawa, Kiyoshi |
Agents permettant de soulager le stress induit par le carbonyle
|
EP1218015A2
(de)
*
|
1999-10-08 |
2002-07-03 |
Novartis AG |
Zusammensetzung welche nateglinide and eine andere antidiabetische verbindung enthält
|
US6274622B1
(en)
*
|
1999-10-27 |
2001-08-14 |
Frederick H. Hausheer |
Method of treating diabetic ophthalmopathy
|
ATE390140T1
(de)
|
1999-11-03 |
2008-04-15 |
Bristol Myers Squibb Co |
Arzneimittel, umfassend eine kombination aus metformin und glibenclamide
|
US6586438B2
(en)
|
1999-11-03 |
2003-07-01 |
Bristol-Myers Squibb Co. |
Antidiabetic formulation and method
|
AR030920A1
(es)
*
|
1999-11-16 |
2003-09-03 |
Smithkline Beecham Plc |
Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
|
US6402771B1
(en)
|
1999-12-23 |
2002-06-11 |
Guidant Endovascular Solutions |
Snare
|
US6575997B1
(en)
|
1999-12-23 |
2003-06-10 |
Endovascular Technologies, Inc. |
Embolic basket
|
US6660021B1
(en)
|
1999-12-23 |
2003-12-09 |
Advanced Cardiovascular Systems, Inc. |
Intravascular device and system
|
WO2001047509A2
(en)
*
|
1999-12-24 |
2001-07-05 |
Smithkline Beecham P.L.C. |
Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions
|
GB9930688D0
(en)
*
|
1999-12-24 |
2000-02-16 |
Smithkline Beecham Plc |
Novel method of treatment
|
US7918820B2
(en)
|
1999-12-30 |
2011-04-05 |
Advanced Cardiovascular Systems, Inc. |
Device for, and method of, blocking emboli in vessels such as blood arteries
|
US6695813B1
(en)
|
1999-12-30 |
2004-02-24 |
Advanced Cardiovascular Systems, Inc. |
Embolic protection devices
|
US20010036479A1
(en)
|
2000-01-14 |
2001-11-01 |
Gillian Cave |
Glyburide composition
|
WO2001052860A2
(en)
*
|
2000-01-24 |
2001-07-26 |
Inotek Corporation |
Method and composition for modulating an immune response
|
US6540982B1
(en)
*
|
2000-01-25 |
2003-04-01 |
Aeropharm Technology Incorporated |
Medical aerosol formulation
|
WO2001058491A1
(fr)
*
|
2000-02-10 |
2001-08-16 |
Takeda Chemical Industries, Ltd. |
Medicament comprenant une combinaison
|
US20030040490A1
(en)
*
|
2000-02-24 |
2003-02-27 |
Yasuo Sugiyama |
Drugs containing combined active ingredients
|
US6451342B2
(en)
|
2000-05-01 |
2002-09-17 |
Aeropharm Technology Incorporated |
Core formulation comprised of troglitazone and a biguanide
|
US6296874B1
(en)
*
|
2000-05-01 |
2001-10-02 |
Aeropharm Technology Incorporated |
Core formulation comprising troglitazone and abiguanide
|
US6461639B2
(en)
|
2000-05-01 |
2002-10-08 |
Aeropharm Technology, Inc. |
Core formulation
|
US6610272B1
(en)
*
|
2000-05-01 |
2003-08-26 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US6548049B1
(en)
*
|
2000-05-01 |
2003-04-15 |
Aeropharm Technology Incorporated |
Medicinal aerosol formulation
|
US6524621B2
(en)
|
2000-05-01 |
2003-02-25 |
Aeropharm Technology Inc. |
Core formulation
|
WO2001082916A2
(en)
|
2000-05-03 |
2001-11-08 |
Tularik Inc. |
Combination therapeutic compositions and methods of use
|
US6270797B1
(en)
*
|
2000-05-18 |
2001-08-07 |
Usv Limited |
Sustained release pharmaceutical composition containing glipizide and method for producing same
|
US6939362B2
(en)
*
|
2001-11-27 |
2005-09-06 |
Advanced Cardiovascular Systems, Inc. |
Offset proximal cage for embolic filtering devices
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
US7563774B2
(en)
|
2000-06-29 |
2009-07-21 |
Metabasis Therapeutics, Inc. |
Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
|
US6964670B1
(en)
|
2000-07-13 |
2005-11-15 |
Advanced Cardiovascular Systems, Inc. |
Embolic protection guide wire
|
US20060089389A1
(en)
*
|
2000-08-22 |
2006-04-27 |
Malcolm Allison |
Combination
|
AR033390A1
(es)
*
|
2000-08-22 |
2003-12-17 |
Novartis Ag |
Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
ATE401886T1
(de)
*
|
2000-10-12 |
2008-08-15 |
Nissan Chemical Ind Ltd |
Wirkstoffe zur vorbeugung und behandlung von komplikationen im zusammenhang mit diabetes
|
US6506203B1
(en)
|
2000-12-19 |
2003-01-14 |
Advanced Cardiovascular Systems, Inc. |
Low profile sheathless embolic protection system
|
CA2725833A1
(en)
|
2001-01-12 |
2002-07-18 |
Sun Pharmaceutical Industries Limited |
Spaced drug delivery system
|
US6852694B2
(en)
|
2001-02-21 |
2005-02-08 |
Medtronic Minimed, Inc. |
Stabilized insulin formulations
|
DE60204611T2
(de)
|
2001-02-28 |
2006-05-11 |
Pfizer Products Inc., Groton |
Sulfonyl-pyridazinon-derivate zur Verwendung als Aldose-reduktase-inhibitoren
|
ES2266494T3
(es)
*
|
2001-03-02 |
2007-03-01 |
Divapharma Chur Ag |
Formulacion combinado para el tratamiento de la de la diabetes mellitas.
|
KR200249057Y1
(ko)
*
|
2001-03-22 |
2001-10-19 |
김진환 |
뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
|
UA73236C2
(en)
|
2001-03-30 |
2005-06-15 |
Pfizer Prod Inc |
Pyridasinones having properties of aldosereductase inhibitors
|
JPWO2002080924A1
(ja)
*
|
2001-04-03 |
2004-07-29 |
山之内製薬株式会社 |
アリールエテンスルホンアミド誘導体の新規な用途
|
DK1377276T3
(da)
*
|
2001-04-10 |
2012-01-02 |
Sun Pharma Advanced Res Co Ltd |
Beregning af puls-frigivelsessammensætning
|
SE0101982D0
(sv)
*
|
2001-06-01 |
2001-06-01 |
Astrazeneca Ab |
Pharmaceutical combination
|
JP2002360666A
(ja)
*
|
2001-06-11 |
2002-12-17 |
Takeda Chem Ind Ltd |
コバルト合金を用いた打錠用杵臼
|
US6737401B2
(en)
*
|
2001-06-28 |
2004-05-18 |
Metronic Minimed, Inc. |
Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom
|
US7338510B2
(en)
|
2001-06-29 |
2008-03-04 |
Advanced Cardiovascular Systems, Inc. |
Variable thickness embolic filtering devices and method of manufacturing the same
|
US6599307B1
(en)
|
2001-06-29 |
2003-07-29 |
Advanced Cardiovascular Systems, Inc. |
Filter device for embolic protection systems
|
MXPA04000176A
(es)
*
|
2001-07-10 |
2004-10-27 |
Kos Life Sciences Inc |
Formulacion de nucleo.
|
AU2001273289B2
(en)
*
|
2001-07-10 |
2004-10-07 |
Kos Life Sciences, Inc. |
Core formulation comprising pioglitazone hydrochloride and a biguanide
|
US6638294B1
(en)
|
2001-08-30 |
2003-10-28 |
Advanced Cardiovascular Systems, Inc. |
Self furling umbrella frame for carotid filter
|
US6592606B2
(en)
|
2001-08-31 |
2003-07-15 |
Advanced Cardiovascular Systems, Inc. |
Hinged short cage for an embolic protection device
|
US8262689B2
(en)
|
2001-09-28 |
2012-09-11 |
Advanced Cardiovascular Systems, Inc. |
Embolic filtering devices
|
EP1452530A4
(de)
|
2001-12-03 |
2005-11-30 |
Japan Tobacco Inc |
Azolverbindung und deren medizinische verwendung
|
US7241304B2
(en)
|
2001-12-21 |
2007-07-10 |
Advanced Cardiovascular Systems, Inc. |
Flexible and conformable embolic filtering devices
|
DE10200138A1
(de)
*
|
2002-01-04 |
2003-07-17 |
Karl Winkler |
Kombination von einem PPAR-Agonisten mit PPAR-alpha Aktivität mit einem Induktor des LDL-Rezeptors
|
TWI327462B
(en)
*
|
2002-01-18 |
2010-07-21 |
Sumitomo Chemical Co |
Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US20030187074A1
(en)
*
|
2002-03-04 |
2003-10-02 |
Javed Hussain |
Oral compositions for treatment of diabetes
|
AR039090A1
(es)
*
|
2002-03-22 |
2005-02-09 |
Novartis Ag |
Combinacion de compuestos organicos
|
AU2003235120A1
(en)
*
|
2002-04-26 |
2003-11-10 |
Takeda Chemical Industries, Ltd. |
Screening method
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US8911781B2
(en)
|
2002-06-17 |
2014-12-16 |
Inventia Healthcare Private Limited |
Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides
|
EP1549296A4
(de)
|
2002-08-02 |
2006-08-09 |
Penwest Pharmaceuticals Co |
Metformin-formulierungen mit verzögerter freisetzung
|
US7232828B2
(en)
*
|
2002-08-10 |
2007-06-19 |
Bethesda Pharmaceuticals, Inc. |
PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
|
ES2529180T3
(es)
|
2002-09-20 |
2015-02-17 |
Andrx Labs Llc |
Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US8084058B2
(en)
|
2002-09-20 |
2011-12-27 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US7252675B2
(en)
|
2002-09-30 |
2007-08-07 |
Advanced Cardiovascular, Inc. |
Embolic filtering devices
|
US7331973B2
(en)
|
2002-09-30 |
2008-02-19 |
Avdanced Cardiovascular Systems, Inc. |
Guide wire with embolic filtering attachment
|
UA80991C2
(en)
|
2002-10-07 |
2007-11-26 |
|
Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
|
US20040088000A1
(en)
|
2002-10-31 |
2004-05-06 |
Muller Paul F. |
Single-wire expandable cages for embolic filtering devices
|
DE10252666A1
(de)
*
|
2002-11-11 |
2004-08-05 |
Grünenthal GmbH |
N-Piperidyl-cyclohexan-Derivate
|
IN192749B
(de)
*
|
2002-11-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
DE10261067A1
(de)
*
|
2002-12-24 |
2004-08-05 |
Nutrinova Nutrition Specialties & Food Ingredients Gmbh |
Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure
|
WO2004065380A1
(en)
|
2003-01-14 |
2004-08-05 |
Arena Pharmaceuticals Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
US6794401B2
(en)
*
|
2003-01-17 |
2004-09-21 |
Bexel Pharmaceuticals, Inc. |
Amino acid phenoxy ethers
|
DE10302452B4
(de)
*
|
2003-01-23 |
2005-02-24 |
Aventis Pharma Deutschland Gmbh |
Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung
|
US7179941B2
(en)
|
2003-01-23 |
2007-02-20 |
Sanofi-Aventis Deutschland Gmbh |
Carbonylamino-substituted acyl phenyl urea derivatives, process for their preparation and their use
|
CA2514539C
(en)
|
2003-01-29 |
2012-03-06 |
Takeda Pharmaceutical Company Limited |
Process for producing coated preparation
|
US7572910B2
(en)
*
|
2003-02-20 |
2009-08-11 |
Pfizer, Inc. |
Pyridazinone aldose reductase inhibitors
|
US8591540B2
(en)
|
2003-02-27 |
2013-11-26 |
Abbott Cardiovascular Systems Inc. |
Embolic filtering devices
|
US20060210633A1
(en)
*
|
2003-04-03 |
2006-09-21 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
KR20050119201A
(ko)
*
|
2003-04-09 |
2005-12-20 |
니뽄 다바코 산교 가부시키가이샤 |
5원 헤테로방향족 고리 화합물 및 이의 의약적 용도
|
US7820158B2
(en)
*
|
2003-04-10 |
2010-10-26 |
Surmodics, Inc. |
Ligand-coupled initiator polymers and methods of use
|
AU2004233691B2
(en)
*
|
2003-04-28 |
2007-09-20 |
Sankyo Company, Limited |
Sugar intake-ability enhancer
|
AU2004233693B2
(en)
*
|
2003-04-28 |
2007-07-19 |
Funahashi, Toru |
Adiponectin production enhancer
|
US20050059708A1
(en)
*
|
2003-05-13 |
2005-03-17 |
Karel Pospisilik |
Processes for making thiazolidinedione derivatives and compounds thereof
|
US7230016B2
(en)
*
|
2003-05-13 |
2007-06-12 |
Synthon Ip Inc. |
Pioglitazone salts, such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
|
US20050004179A1
(en)
*
|
2003-05-22 |
2005-01-06 |
Pedersen Ward A. |
Methods and materials for treating, detecting, and reducing the risk of developing Alzheimer's Disease
|
AU2004250994B2
(en)
*
|
2003-06-27 |
2010-12-02 |
Dr. Reddy's Research Foundation |
Compositions comprising balaglitazone and further antidiabetic compounds
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
WO2005012485A2
(en)
*
|
2003-07-31 |
2005-02-10 |
Bayer Pharmaceuticals Corporation |
Methods for treating diabetes and related disorders using pde10a inhibitors
|
EP1510208A1
(de)
*
|
2003-08-22 |
2005-03-02 |
Fournier Laboratories Ireland Limited |
Metformin-Statin-Kombination enthaltende pharmazeutische Zusammensetzungen
|
US20050054731A1
(en)
*
|
2003-09-08 |
2005-03-10 |
Franco Folli |
Multi-system therapy for diabetes, the metabolic syndrome and obesity
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
BRPI0415781A
(pt)
*
|
2003-10-27 |
2006-12-26 |
Innodia Inc |
método para o tratamento de diabetes em um paciente e kit farmacêutico
|
CN1874774B
(zh)
|
2003-10-31 |
2011-04-13 |
武田药品工业株式会社 |
包含胰岛素致敏剂、胰岛素促分泌素和聚氧乙烯脱水山梨醇脂肪酸酯的固体制剂
|
US7892251B1
(en)
|
2003-11-12 |
2011-02-22 |
Advanced Cardiovascular Systems, Inc. |
Component for delivering and locking a medical device to a guide wire
|
WO2005065654A2
(en)
*
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone formulations
|
WO2005065663A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone and metformin formulations
|
US7360069B2
(en)
*
|
2004-01-13 |
2008-04-15 |
Hewlett-Packard Development Company, L.P. |
Systems and methods for executing across at least one memory barrier employing speculative fills
|
EP1555021A1
(de)
*
|
2004-01-16 |
2005-07-20 |
National Health Research Institutes |
Kombinationen eines Mevalonat-Weg-Inhibitoren und eines PPAR-Gamma-Agonisten für die Behandlung von Krebs
|
EP1714648A4
(de)
*
|
2004-02-09 |
2010-05-26 |
Aska Pharm Co Ltd |
Kombinationsarzneimittel
|
WO2005080387A2
(en)
*
|
2004-02-20 |
2005-09-01 |
Synthon B.V. |
Processes for making pioglitazone and compounds of the processes
|
EP1734953A4
(de)
*
|
2004-03-02 |
2008-08-20 |
Abeille Pharmaceuticals Inc |
Co-formulierungen von kits von bioaktiven mitteln
|
US7678129B1
(en)
|
2004-03-19 |
2010-03-16 |
Advanced Cardiovascular Systems, Inc. |
Locking component for an embolic filter assembly
|
US7161756B2
(en)
*
|
2004-05-10 |
2007-01-09 |
Tandberg Data Storage Asa |
Method and system for communication between a tape drive and an external device
|
CN1327840C
(zh)
*
|
2004-06-08 |
2007-07-25 |
天津药物研究院 |
一种药物组合物及其在制备用于治疗糖尿病中的应用
|
AU2005271526B2
(en)
*
|
2004-08-03 |
2011-12-08 |
Emisphere Technologies, Inc. |
Antidiabetic oral insulin-biguanide combination
|
CN101432004A
(zh)
*
|
2004-09-14 |
2009-05-13 |
伊利舍医药品公司 |
用于控制的碳水化合物消化的联合治疗
|
MXPA04009236A
(es)
*
|
2004-09-23 |
2006-03-27 |
Jorge Luis Rosado Loria |
Composicion sinergistica para el tratamiento de diabetes y sus comorbilidades.
|
JP2008019169A
(ja)
*
|
2004-10-25 |
2008-01-31 |
Osaka Univ |
新規ppar調節剤およびそのスクリーニング方法
|
US20060089387A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Le Huang |
Stabilized pharmaceutical composition comprising antidiabetic agent
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
US9259305B2
(en)
|
2005-03-31 |
2016-02-16 |
Abbott Cardiovascular Systems Inc. |
Guide wire locking mechanism for rapid exchange and other catheter systems
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
GT200600218A
(es)
*
|
2005-06-10 |
2007-03-28 |
|
Formulación y proceso de compresión directa
|
JP2009500401A
(ja)
*
|
2005-07-07 |
2009-01-08 |
ポステック ファンデーション |
糖吸収調節剤及び薬学的組成物
|
WO2007011524A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Franco Folli |
Daily dosage regimen for treating diabetes, obsity, metabolic syndrome and polycystic ovary syndrome
|
BRPI0613670A2
(pt)
*
|
2005-07-22 |
2011-01-25 |
Procter & Gamble |
composições para redução da incidência de arritmia induzida por fármacos
|
MXPA05013220A
(es)
*
|
2005-12-06 |
2007-06-05 |
Leopoldo De Jesus Espinosa Abdala |
Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.
|
TWI384985B
(zh)
|
2005-12-22 |
2013-02-11 |
Takeda Pharmaceutical |
固體製劑
|
FR2896157B1
(fr)
|
2006-01-13 |
2008-09-12 |
Merck Sante Soc Par Actions Si |
Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
|
WO2007105730A1
(ja)
*
|
2006-03-13 |
2007-09-20 |
Kyowa Hakko Kogyo Co., Ltd. |
インスリン抵抗性改善剤
|
PL2902026T3
(pl)
|
2006-03-16 |
2018-03-30 |
Metabolic Solutions Development Company Llc |
Analogi tiazolidynodionu do leczenia choroby metabolicznej pośredniczonej przez zapalenie
|
JP2009532372A
(ja)
*
|
2006-03-31 |
2009-09-10 |
ウェルスタット セラピューティクス コーポレイション |
代謝障害の併用治療
|
MX2008013157A
(es)
*
|
2006-04-11 |
2009-02-23 |
Sorbwater Technology As |
Metodo para eliminar materiales de un flujo liquido.
|
US7435741B2
(en)
*
|
2006-05-09 |
2008-10-14 |
Teva Pharmaceutical Industries, Ltd. |
2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
|
CA2654661C
(en)
|
2006-06-26 |
2012-10-23 |
Amgen Inc. |
Compositions comprising modified lcat and use thereof for treating atherosclerosis
|
US7752724B2
(en)
*
|
2006-06-27 |
2010-07-13 |
Lumino, Inc. |
Method of cutting blinds
|
WO2008026668A1
(fr)
*
|
2006-08-31 |
2008-03-06 |
Daiichi Sankyo Company, Limited |
Composition médicale contenant un agent d'amélioration de la résistance à l'insuline
|
US20080182880A1
(en)
*
|
2006-09-28 |
2008-07-31 |
Mailatur Sivaraman Mohan |
Pioglitazone composition
|
US8217025B2
(en)
*
|
2006-11-17 |
2012-07-10 |
Harbor Therapeutics, Inc. |
Drug screening and treatment methods
|
WO2008091624A2
(en)
*
|
2007-01-22 |
2008-07-31 |
Teva Pharmaceutical Industries Ltd. |
Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
|
NZ579229A
(en)
|
2007-01-25 |
2011-07-29 |
Verva Pharmaceuticals Ltd |
Insulin sensitisers and methods of treatment
|
ES2354397T3
(es)
*
|
2007-02-01 |
2011-03-14 |
Takeda Pharmaceutical Company Limited |
Preparación sólida que comprende alogliptina y pioglitazona.
|
WO2008124122A1
(en)
*
|
2007-04-09 |
2008-10-16 |
Scidose, Llc |
Combinations of statins and anti-obesity agent and glitazones
|
US20160331729A9
(en)
*
|
2007-04-11 |
2016-11-17 |
Omeros Corporation |
Compositions and methods for prophylaxis and treatment of addictions
|
US11241420B2
(en)
|
2007-04-11 |
2022-02-08 |
Omeros Corporation |
Compositions and methods for prophylaxis and treatment of addictions
|
ES2586433T3
(es)
|
2007-04-11 |
2016-10-14 |
Omeros Corporation |
Composiciones y métodos para la profilaxis y el tratamiento de adicciones
|
US8216209B2
(en)
|
2007-05-31 |
2012-07-10 |
Abbott Cardiovascular Systems Inc. |
Method and apparatus for delivering an agent to a kidney
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
EA020466B1
(ru)
|
2007-06-04 |
2014-11-28 |
Синерджи Фармасьютикалз Инк. |
Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
|
US7867273B2
(en)
|
2007-06-27 |
2011-01-11 |
Abbott Laboratories |
Endoprostheses for peripheral arteries and other body vessels
|
EP2489730B1
(de)
|
2007-07-26 |
2015-12-30 |
Amgen, Inc |
Modifizierte Lecithin-Cholesterin-Acyltransferase-Enzyme
|
ES2398313T3
(es)
*
|
2007-09-14 |
2013-03-15 |
Metabolic Solutions Development Company Llc |
5-(4-(2-(3-metoxifenil)-2-oxoetoxi)bencil)tiazolidin-2,4-diona para uso en el tratamiento de la diabetes
|
WO2009038107A1
(ja)
*
|
2007-09-21 |
2009-03-26 |
Kissei Pharmaceutical Co., Ltd. |
2型糖尿病治療用の組合せ医薬
|
WO2009073627A1
(en)
*
|
2007-11-30 |
2009-06-11 |
The Research Foundation Of State University Of New York |
Metabolic fuel switching biomarker
|
US8551524B2
(en)
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
EP2190417A2
(de)
*
|
2008-03-26 |
2010-06-02 |
Teva Pharmaceutical Industries Ltd. |
Pharmazeutische zusammensetzung mit insulinsensibilisator und insulinsekretagogum
|
JP2011522828A
(ja)
|
2008-06-04 |
2011-08-04 |
シナジー ファーマシューティカルズ インコーポレイテッド |
胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
|
CA2730603C
(en)
|
2008-07-16 |
2019-09-24 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
SI2324126T1
(sl)
|
2008-08-12 |
2014-07-31 |
Zinfandel Pharmaceuticals, Inc. |
Postopek identifikacije dejavnikov tveganja za Alzheimerjevo bolezen
|
US8846315B2
(en)
|
2008-08-12 |
2014-09-30 |
Zinfandel Pharmaceuticals, Inc. |
Disease risk factors and methods of use
|
TW201031664A
(en)
|
2009-01-26 |
2010-09-01 |
Targacept Inc |
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
|
KR20170093264A
(ko)
|
2009-03-11 |
2017-08-14 |
오메로스 코포레이션 |
중독의 예방 및 치료용 조성물 및 방법
|
US20110038848A1
(en)
*
|
2009-08-12 |
2011-02-17 |
Melaleuca, Inc. |
Dietary supplement compositions for cardiovascular health
|
CA2780683A1
(en)
|
2009-11-13 |
2011-05-19 |
Toray Industries, Inc. |
Therapeutic or prophylactic combination of a prostaglandin i2 and a thiazolidine for diabetes
|
EP2509602B9
(de)
*
|
2009-12-04 |
2017-11-01 |
Senhwa Biosciences, Inc. |
Pyrazolopyrimidine und entsprechende heterocyclen als ck2-hemmer
|
PL2512470T3
(pl)
*
|
2009-12-15 |
2017-06-30 |
Octeta Therapeutics, Llc |
Oszczędzające ppar tiazolidynodiony i połączenia do leczenia chorób neurodegeneracyjnych
|
CA2783468C
(en)
*
|
2009-12-15 |
2018-10-09 |
Metabolic Solutions Development Company, Llc |
Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases
|
WO2011120923A1
(en)
|
2010-03-30 |
2011-10-06 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof
|
BR112012025592A2
(pt)
*
|
2010-04-06 |
2019-09-24 |
Arena Pharm Inc |
moduladores do receptor de gpr119 e o tratamento de distúrbios relacionados com os mesmos
|
RU2526153C2
(ru)
*
|
2010-07-15 |
2014-08-20 |
Олег Ильич Эпштейн |
Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
|
WO2012028934A1
(en)
|
2010-09-01 |
2012-03-08 |
Lupin Limited |
Pharmaceutical composition comprising metformin and pioglitazone
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
PE20131371A1
(es)
|
2010-09-22 |
2013-11-25 |
Arena Pharm Inc |
Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con este
|
KR20180050420A
(ko)
|
2011-01-10 |
2018-05-14 |
진판델 파마슈티컬스 인코포레이티드 |
알츠하이머 병 치료를 위한 방법 및 약품
|
US9566269B2
(en)
|
2011-01-20 |
2017-02-14 |
Bionevia Pharmaceuticals Inc. |
Modified release compositions of epalrestat or a derivative thereof and methods for using the same
|
WO2013034174A1
(en)
|
2011-09-06 |
2013-03-14 |
ZENTIVA Saglik Ürünleri Sanayi ve Ticaret A.S. |
Solid preparations of pioglitazone and glimepiride
|
US20140243281A1
(en)
|
2011-10-28 |
2014-08-28 |
Lumena Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
|
JP6635655B2
(ja)
|
2011-12-08 |
2020-01-29 |
アムジエン・インコーポレーテツド |
ヒトlcat抗原結合タンパク質および治療法におけるそれらの使用
|
US9504679B2
(en)
|
2011-12-19 |
2016-11-29 |
Bjoern Colin Kahrs |
Pharmaceutical compositions comprising glitazones and Nrf2 activators
|
US20130158077A1
(en)
|
2011-12-19 |
2013-06-20 |
Ares Trading S.A. |
Pharmaceutical compositions
|
JP2016514670A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
KR102272746B1
(ko)
|
2013-06-05 |
2021-07-08 |
보슈 헬스 아일랜드 리미티드 |
구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
|
EP3065757A4
(de)
|
2013-10-09 |
2017-08-23 |
Synergy Pharmaceuticals Inc. |
Gunaylat-cyclase-agonisten zur herunterregulierung von pro-inflammatorischen zytokinen
|
RU2572706C1
(ru)
*
|
2014-06-30 |
2016-01-20 |
Олег Ильич Эпштейн |
Способ повышения фармакологической активности действующего вещества лекарственного средства и фармацевтическая композиция
|
KR20170115071A
(ko)
|
2015-02-06 |
2017-10-16 |
인터셉트 파마슈티컬즈, 인크. |
병용 요법을 위한 약제학적 조성물
|
CA3002551A1
(en)
|
2015-06-22 |
2016-12-29 |
Arena Pharmaceuticals, Inc. |
Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid(com pound 1)for use in s1p1 receptor-associated disorders
|
US20190350907A1
(en)
|
2017-01-16 |
2019-11-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for reducing cd95- mediated cell motility
|
EP3807895A1
(de)
|
2018-06-14 |
2021-04-21 |
AstraZeneca UK Limited |
Verfahren zur senkung des blutzuckers mit einer pharmazeutischen metforminzusammensetzung
|
CN114144185A
(zh)
|
2019-05-30 |
2022-03-04 |
英特塞普特医药品公司 |
用于治疗胆汁淤积性肝病的包含fxr激动剂和贝特类的药物组合物
|
CN112869173A
(zh)
*
|
2021-01-18 |
2021-06-01 |
广州富诺营养科技有限公司 |
一种复合维生素矿物质制剂及其制备方法
|